DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ shed 5.26% to $546.39 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 3.46% to 5,268.05 and Dow Jones Industrial Average falling 2.50% to 39,593.66.
Regeneron Pharmaceuticals Inc. closed 54.89% short of its 52-week high of $1,211.20, which the company reached on August 27th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amgen Inc. $(AMGN)$ fell 3.33% to $281.41, Moderna Inc. $(MRNA)$ fell 8.14% to $24.50, and Gilead Sciences Inc. $(GILD)$ fell 3.66% to $101.40.
Trading volume (1.3 M) eclipsed its 50-day average volume of 1.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 10, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 10, 2025 16:45 ET (20:45 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。